Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02207400 · ClinicalTrials.gov registry record · Phase 2
To Evaluate Efficacy and Tolerability of Sodium Bicarbonate Toothpaste and Its Effect on Opportunistic or Resistant Organisms
A Phase 2 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 246
- Enrollment target
NCT02207400 is a Phase 2 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 246 participants.
The verdict
NCT02207400, a Phase 2 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 246 participants
- Enrollment target
Study Summary
This study will compare the Gingival Bleeding and Gingival Inflammation following twice daily use of a sodium bicarbonate experimental dentifrice compared to a 0% sodium bicarbonate toothpaste after 24 weeks of use. The study will be conducted at Salus Research, Inc. Participants will be recruited from their database and by use of an external recruitment agency
Interventions
- DRUG Sodium fluoride
- DRUG Sodium bicarbonate and sodium fluoride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2014-08-25 |
| Est. Completion | 2015-04-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02207400
The ClinicalTrials.gov registry entry for NCT02207400 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 246 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sodium fluoride is the first listed.
NCT02207400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02207400 about?
NCT02207400 is a clinical study titled "To Evaluate Efficacy and Tolerability of Sodium Bicarbonate Toothpaste and Its Effect on Opportunistic or Resistant Organisms". This study will compare the Gingival Bleeding and Gingival Inflammation following twice daily use of a sodium bicarbonate experimental dentifrice compared to a 0% sodium bicarbonate toothpaste after 24 weeks of use. The study will be conducted at Salus Research, Inc. Participants will be recruited f...
What is the current status of trial NCT02207400?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 246 participants. The study started on 2014-08-25. Estimated completion is 2015-04-30.
What interventions are being tested in trial NCT02207400?
The interventions under investigation include: Sodium fluoride (DRUG), Sodium bicarbonate and sodium fluoride (DRUG).
Who is sponsoring clinical trial NCT02207400?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.